Transcatheter aortic valve implantation with the ACURATE Neo valve: indications, procedural aspects and clinical outcomes

DOI: 10.4244/EIJ-D-19-00908

Main Authors:

Won-Keun Kim¹,; Christian Hengstenberg²; Michael Hilker³; Ulrich Schäfer⁴; Tanja K. Rudolph⁵; Stefan Toggweiler⁶; Andreas Rück⁷; Lars Sondergaard⁸; Lenard Conradi⁹; Christian Hamm¹⁰; Thomas Walther¹¹; Helge Möllmann¹²;

Collaborators:

Mirko Doss¹³; Andreas Holzamer³; Oliver Husser¹²; Cindy Belon¹⁴; Stefane Delaloye¹⁴;

1. Kerckhoff Heart Center, Department of Cardiology, Bad Nauheim, Germany, Kerckhoff Heart Center, Department of Cardiac Surgery, Bad Nauheim, Germany; Justus-Liebig University of Giessen, Department of Cardiology, Giessen, Germany, Germany
2. Department of Medicine II, University Departments of the MedUni, Vienna, Austria
3. University Medical Center, Department of Cardiothoracic Surgery, Regensburg, Germany
4. Marienkrankenhaus, Department of Cardiology, Angiology, and Intensive Care Medicine, Hamburg, Germany
5. Herz- und Diabeteszentrum NRW, Department of Cardiology, Ruhr-University Bochum, Bad Oeynhausen, Germany
6. Heart Center Lucerne, Lucerner Kantonsspital, Lucerne, Switzerland
7. Karolinska University Hospital, Stockholm, Sweden
8. The Heart Center, Rigshospitalet, Copenhagen, Denmark
9. University Heart Center, Department of Cardiovascular Surgery, University Hospital Hamburg-Eppendorf (UKE), Germany
10. Kerckhoff Heart Center, Department of Cardiology, Bad Nauheim, Germany. Justus-Liebig University of Giessen, Department of Cardiology, Giessen, Germany
11. University Heart Center, Department of Cardiovascular Surgery, Johann-Wolfgang-Goethe University, Frankfurt, Germany
12. St. Johannes Hospital, Department of Cardiology, Dortmund, Germany
13. Kerckhoff Heart Center, Department of Cardiac Surgery, Bad Nauheim, Germany
14. Boston Scientific, Ecublens, Switzerland

Disclaimer:

As a public service to our readership, this article - peer reviewed by the Editors of EuroIntervention - has been published immediately upon acceptance as it was received. The content of this article is the sole responsibility of the authors, and not that of the journal or its publishers.

Please note that supplementary movies are not available online at this stage. Once a paper is published in its edited and formatted form, it will be accompanied online by any supplementary movies.

To read the full content of this article, please download the PDF. Download full article (PDF)

The ACURATE neo aortic valve system is a self-expanding transcatheter device that was granted CE mark in 2014 and since has been widely adopted in the treatment of patients with severe aortic stenosis. The ACURATE neo can be used in a wide clinical spectrum, but there are some specific indications and anatomies where this device is particularly suitable. Recently it was shown that with appropriate patient screening, size selection, and optimized positioning, results can be improved substantially. This review provides an overview of existing data and compiles a standardized manual of best practice for the implantation of this device based on both evidence and individual experience.

Forgot your password?

No account yet? Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

aortic stenosistavitraining and education

Interventions for valvular diseaseTAVI

Share on Facebook Share on Twitter Share on Linkedin